![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Convatec Group Plc | LSE:CTEC | London | Ordinary Share | GB00BD3VFW73 | ORD 10P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-1.20 | -0.49% | 243.20 | 243.00 | 243.40 | 245.20 | 242.20 | 244.80 | 10,007,813 | 16:35:12 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Med, Dental, Hosp Eq-whsl | 2.14B | 130.3M | 0.0636 | 38.21 | 5.01B |
Convatec Group PLC (CTEC) Convatec Group PLC: Company Secretary Change 15-Aug-2023 / 12:00 GMT/BST =---------------------------------------------------------------------------------------------------------------------- 15 August 2023 Convatec Group Plc ("Convatec" or "the Company") Appointment of Company Secretary The Board of Directors of Convatec Group Plc has approved the appointment of Robyn Butler-Mason as Company Secretary with effect from 1st September 2023, whereupon Evelyn Douglas will resign as Company Secretary with effect from that date. Evelyn Douglas will continue in her role as EVP, Chief of Corporate Strategy and Business Development and General Counsel. Enquiries Grace McCalla, Assistant Company Secretary +44(0)7575353388 Cosec@convatec.com Convatec Group Plc's LEI code is 213800LS272L4FIDOH92 About Convatec Pioneering trusted medical solutions to improve the lives we touch: Convatec is a global medical products and technologies company, focused on solutions for the management of chronic conditions, with leading positions in advanced wound care, ostomy care, continence care and infusion care. With around 10,000 colleagues, we provide our products and services in almost 100 countries, united by a promise to be forever caring. Our solutions provide a range of benefits, from infection prevention and protection of at-risk skin, to improved patient outcomes and reduced care costs. Group revenues in 2022 were over USD2 billion. The company is a constituent of the FTSE 100 Index (LSE:CTEC). To learn more about Convatec, please visit www.convatecgroup.com. =---------------------------------------------------------------------------------------------------------------------- Dissemination of a Regulatory Announcement, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement. =---------------------------------------------------------------------------------------------------------------------- ISIN: GB00BD3VFW73 Category Code: COS TIDM: CTEC LEI Code: 213800LS272L4FIDOH92 Sequence No.: 264766 EQS News ID: 1704013 End of Announcement EQS News Service =------------------------------------------------------------------------------------
Image link: https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=show_t_gif&application_id=1704013&application_name=news
(END) Dow Jones Newswires
August 15, 2023 07:00 ET (11:00 GMT)
1 Year Convatec Chart |
1 Month Convatec Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions